In Other News

• Routine Opt-Out Screening Helps Increase Detection of Adolescent STIs

• Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

• Comprehensive Tumor Profiling Uncovers Overlooked Hereditary Cancer Risk Genes

• Nonendoscopic Methylation Assay Enables Rapid Barrett’s Esophagus Screening

• New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

• Studies Support MRD Testing to Detect Head and Neck Cancer Recurrence

• New qPCR Master Mixes Offer Broad Compatibility for Routine Research

• Agilent Completes Acquisition of Digital Pathology Platform Developer Proscia

• New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

• New qPCR Master Mixes Offer Broad Compatibility for Routine Research

• New Diagnostics Company Onvaro Formed to Expand Decentralized Testing

• Exhaled Breath Particles Reveal Virus-Specific Antibodies in the Lower Airways

• Tumor and Immune Biomarkers Linked to Treatment Response in T-Cell Lymphoma

• Platelet Biomarkers Identify Progression Signals in Parkinson's Disease

• Genomic Profiling Predicts Relapse Risk by Subtype in Pediatric Leukemia

• Newly Certified FISH Probes Support Cytogenetic Testing in Blood Cancers

• New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

• New ddPCR Assays Broaden Options for Multiplex Cancer Mutation Research

• AI-Supported Approach May Improve Cervical Cancer Screening in Low-Resource Settings

• Molecular AI Model Refines Risk Prediction in Pediatric Brain Tumors

• Molecular Atlas Offers New Framework for Breast Cancer Risk and Treatment Research

• Multi-Agent AI Framework Supports Laboratory Quality and Workflow Monitoring

• Multiplex PCR Panel Gains FDA Clearance for Viral Hemorrhagic Fever Detection